Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis

Injury Epidemiology

Volumn 2, Issue 1, 2015, Pages

  Giglio, Rebecca E ^a   Li, Guohua ^a,b,c   DiMaggio, Charles J ^b,d  

^a Howard Hughes Medical Institute   (United States)

^b Mailman School of Public Health   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bystander; Naloxone; Opioid overdose; Overdose prevention

Indexed keywords

NALOXONE;

ARTICLE; CASE MANAGEMENT; DRUG OVERDOSE; HEALTH PROGRAM; HUMAN; ICD-10; META ANALYSIS; NONMEDICAL OCCUPATIONS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM; TRAINING;

EID: 84938608230     PISSN: None     EISSN: 21971714     Source Type: Journal    
DOI: 10.1186/s40621-015-0041-8     Document Type: Article

References (33)

1. Bigg D. Data on take home naloxone are unclear but not condemnatory. BMJ. 2002;324(7338):678.
2. Borenstein M, Hedges LV, Higgins JPT, Rothenstein HR. Fixed effect versus random effects models. In: Introduction to Meta-analysis. Chichester, West Sussex, England: John Wiley & Sons Ltd; 2009. p. 77–85.
3. CDC. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. Morb Mortal Wkly Rep. 2012;61(06):101–5.
4. CDC. Increases in heroin overdose deaths - 28 States, 2010 to 2012. Morb Mortal Wkly Rep. 2014a;63(39):849–54. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6339a1.htm?s_cid=mm6339a1_w. Accessed 7 Jan 2015.
5. CDC. National vital statistics system mortality data. 2015. http://www.cdc.gov/nchs/deaths.htm. Accessed 7 Jan 2015.
6. CDC. Prescription drug overdose in the United States: fact sheet. 2014b. http://www.cdc.gov/drugoverdose/index.html. Accessed 7 Jan 2015.
7. CDC. Web-based Injury Statistics Query and Reporting System (WISQARS). 2014c. http://www.cdc.gov/injury/wisqars/fatal.html. Accessed 7 Jan 2015.
8. Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153–63.
9. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.
10. Davis C. Legal interventions to reduce overdose mortality: naloxone access and overdose good Samaritan laws. 2014.
11. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006;31(5):907–12.
12. Gaston RL, Best D, Manning V, Day E. Can we prevent drug related deaths by training opioid users to recognize and manage overdoses? Harm Reduction J. 2009;6:26.
13. Goodman DJ. Drug to stop heroin deaths is more costly, the police say. The New York Times. The New York Times Company; 2014. p. A22.
14. Green TC, Grau LE, Heimer R. Medical expert agreement of drug user reported overdose symptoms. London: International Harm Reduction Association; 2006.
15. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction (Abingdon, England). 2008;103(6):979–89.
16. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
17. 2 index? Psychol Methods. 2006;11(2):193.
18. Jinks A, Cotton A, Rylance R. Obesity interventions for people with a learning disability: an integrative literature review. J Adv Nurs. 2011;67(3):460–71.
19. Jones JD, Roux P, Stancliff S, Matthews W, Comer SD. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. Int J Drug Policy. 2014;25(1):166–70.
20. Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99(3):402–7.
21. Lankenau SE, Wagner KD, Silva K, Kecojevic A, Iverson E, McNeely M, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health. 2013;38(1):133–41.
22. Law Atlas. Naloxone overdose prevention laws map. http://lawatlas.org/query?dataset=laws-regulating-administration-of-naloxone#.VDWYO7HD-mQ (2014). Accessed 7 Jan 2015.
23. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96.
24. McAuley A, Lindsay G, Woods M, Louttit D. Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Policy. 2010;17(4):388–99.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
26. Reuters T. EndNote (X7 for windows) [computer program]. 2013.
27. Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose. J Urban Health. 2003;80:291–301.
28. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82(2):303–11.
29. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130(7):584–90.
30. Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction (Abingdon, England). 2008;103(10):1648–57.
31. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
32. Williams AV, Marsden J, Strang J. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction (Abingdon, England). 2014;109(2):250–9.
33. World Health Organization. Community management of opioid overdose. Geneva, Switzerland: World Health Organization; 2014.